One Last SPAC to Close Out August and Bring the Month’s Deal Count to Seven.
To cap off a very busy August, Longevity Acquisition Corporation, filed their CERT today, indicating they will be pricing their IPO tonight for trading Wednesday (Nasdaq: LOACU).
Longevity, which will be focusing on companies in China, will be looking to raise $40 million at IPO. However, there is always the possibility of an upsize given how attractive the China-focused SPAC structures are to investors. Specifically, the terms provide 12 months to find an acquisition, but with three(3) 3-month extensions possible with an increase of $0.10 per share added to the trust for each extension.
The $40 million Longevity deal ends the SPAC-abundant summer on a high note. To give some perspective on just how busy it actually was, in the past three months alone, (June, July, and August), there will be 16 deals, including Longevity, raising total gross proceeds of $3.772 billion. Looking at January through May, which has two extra months, only $3.354 billion was raised over 15 deals.
We have four more months left in the year. Anybody want to start a pool on what we think final deal count and gross proceeds will be?
Cantor is sole bookrunning manager for Longevity Acquisition Corp.
Longevity Acquisition Corporation Summary of Terms:
- Focus: China
- Size: $40 million
- $10.00 unit comprised of one Ordinary Share + one Warrant (1/2 share) + one Right
- Each Right entitles the holder to receive one-tenth (1/10) of one Share
- Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
- 100% held in trust ($10.00 per share)
- Life: 12 months to complete an acquisition + three 3-month extensions ($0.10/share added to Trust for each extension)
- Limitation on Redemption Rights: 15%
- At-risk Capital: $2.7 million (270K private placement units, Cantor participating for 20K units)
- Underwriter fees: 3.0% + 2.5% deferred.
Cantor Fitzgerald is sole book-runner.
Ellenoff Grossman & Schole LLP and Loeb & Loeb LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...
Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...
Despite a week of general pull-backs in the market, fintech firm Ibotta (NYSE:IBTA) nonetheless took the dive and had a good week debuting via a traditional IPO in the choppy waters. The company, which provides app-based consumer cashback discounts on purchases, priced its IPO at $88, above its proposed range of $76 to $84, and...
At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...